Prostate cancer screening pilot program

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funders: European Commission and 2 more
  • Human trial1

Outcomes

2

2-yr PSA testing rate

upin humans1

1 study
  1. Prostate cancer screening pilot program increases 2-yr PSA testing rate in humans (from 47.4% to 53.3%).

    “From 2023 to 2024, the 2-yr PSA testing rate rose from 47.4% to 53.3%”

    Human trialorganized screening pilot program12 momalesn = 150,498

    Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program

    European urology open science25 Jul 2026

More on 2-yr PSA testing rate

Prebiopsy MRI use

upin humans1

1 study
  1. Prostate cancer screening pilot program increases prebiopsy MRI use in humans (10.3 percentage-point difference, 95% CI 8.3-12.2).

    “prebiopsy MRI use increased from 28.0% to 38.3% (10.3 percentage-point difference, 95% confidence interval 8.3-12.2)”

    Human trialorganized screening pilot program12 momalesn = 150,498

    Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program

    European urology open science25 Jul 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months